Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma

M. J.E. Greuter*, J. J. Eertink, PETRA consortium, G. Jongeneel, U. Dührsen, A. Hüttmann, C. Schmitz, P. J. Lugtenburg, S. F. Barrington, N. G. Mikhaeel, L. Ceriani, E. Zucca, R. Carr, T. Györke, C. N. Burggraaff, H. C.W. de Vet, O. S. Hoekstra, J. M. Zijlstra, V. M.H. Coupé

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma'. Together they form a unique fingerprint.

Social Sciences

Nursing and Health Professions

Economics, Econometrics and Finance

Medicine and Dentistry